Latest News & Features
Europe
UPC rejects jurisdictional challenges from Moderna | Court allows two linked infringement cases over mRNA tech to move forward in The Hague | Ruling finds commercial links between Moderna entities enough to justify its jurisdiction over non-UPC territories. 27 May 2025
Careers
New hire is a specialist in pharmaceutical regulatory matters, complex patent disputes, and cross-border transactional support for biotech. 27 May 2025
Europe
With the regime affecting UK exports to the EEA set to continue, Charlotte Peach of Taylor Wessing explores some of the practical implications for businesses. 27 May 2025
Europe
Artificial intelligence is undoubtedly impacting the biotech lifecycle, and presents myriad applications—and risks. Tim Powell, Vishnu Shankar and Ben Rowlatt of Morgan Lewis provide a detailed analysis. 22 May 2025
Europe
AstraZeneca subsidiary Alexion suffers setback in bid to stop rivals launching biosimilars of blood disorder drug | Ruling concerns an error in original patent application | Decision follows UPC defeat for Alexion over eculizumab patent. 22 May 2025
Americas
South Korean company eyes new business opportunities following Supreme Court ruling | Pfizer had claimed infringement of patent covering Prevenar 13 shot. 22 May 2025
Europe
Etienne Sanz de Acedo tells Tom Phillips that the association is looking at incentives to keep delegates at the official convention centre, which is not in the city centre. 22 May 2025
Americas
A lively session explored findings from a report co-authored by LSIPR sister title WIPR, urging the IP sector to call time on outdated metrics that delay or derail women’s professional progress. 22 May 2025
Americas
Boards of Appeal revokes Genzyme patent, handing win to Accord Healthcare | Teva and Hetero Labs also previously filed oppositions | Patent refers to Cerdelga, part of Sanofi’s Gaucher disease franchise. 20 May 2025
Americas
Trademark association confirms UK host city at opening ceremony after news accidentally shared on social media the day before | New mission statement and four-year plan embraces diversity and inclusion | ‘We are, as an organisation, a citizen of the world’ says CEO. 20 May 2025